XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 29, 2022
Oct. 30, 2021
Operating activities    
Net loss $ (27,394) $ (9,997)
Add (deduct) items not affecting operating cash flows:    
Impairment of intangible assets 1,700  
Impairment of long-lived assets 866  
Depreciation and amortization 5,828 4,644
Provision for bad debt 149 (48)
Loss on disposal of property and equipment 72  
Amortization of deferred financing costs 734 562
Deferred income taxes 1,039 1,656
Share-based compensation expense 1,637 1,485
Capitalized PIK Interest 1,917 1,721
Loss on debt extinguishment   1,501
Changes in assets and liabilities:    
Receivables, net (301) (355)
Inventories (37,913) (13,810)
Prepaid expenses and other current assets 718 2,056
Accounts payable and accrued expenses 20,954 9,663
Other assets and liabilities 1,108 (3,326)
Net cash used in operating activities (28,886) (4,248)
Investing activities    
Payments for capital expenditures (2,100) (4,124)
Net cash used in investing activities (2,100) (4,124)
Financing activities    
Proceeds from borrowings under the Revolving Credit Facilities 304,952 234,445
Repayment of borrowings under the Revolving Credit Facilities (272,375) (236,397)
Repayment of borrowings under the Term Loan Facilities (1,750) (24,750)
Proceeds from borrowings under the Term Loan Facilities   35,000
Proceeds from common stock issuance, net of certain fees 825  
Tax withholdings related to restricted stock vesting (210) (66)
Proceeds from stock option exercises, restricted stock vesting, and issuance of common stock under employee stock purchase plan 58 73
Financing fees (406) (2,151)
Net cash provided by financing activities 31,094 6,154
Increase (decrease) in cash, cash equivalents, and restricted cash 108 (2,218)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (12) 6
Cash, cash equivalents, and restricted cash, beginning of period 1,096 3,858
Cash, cash equivalents, and restricted cash, end of period 1,192 1,646
Less: restricted cash at end of period 35 41
Cash and cash equivalents 1,157 1,605
Supplemental Disclosures of Cash Flow Information    
Cash payments for interest 2,479 3,359
Cash payments for income taxes, net of refunds 68 67
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Capital expenditures in accounts payable and accrued liabilities 76 384
Deferred financing fees in accrued liabilities $ 1,675 $ 150